HEADER HYDROLASE/HYDROLASE INHIBITOR 16-MAR-04 1SP4 TITLE CRYSTAL STRUCTURE OF NS-134 IN COMPLEX WITH BOVINE CATHEPSIN B: A TWO TITLE 2 HEADED EPOXYSUCCINYL INHIBITOR EXTENDS ALONG THE WHOLE ACTIVE SITE TITLE 3 CLEFT COMPND MOL_ID: 1; COMPND 2 MOLECULE: CATHEPSIN B; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: LIGHT CHAIN; COMPND 5 EC: 3.4.22.1; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: CATHEPSIN B; COMPND 8 CHAIN: B; COMPND 9 FRAGMENT: HEAVY CHAIN; COMPND 10 EC: 3.4.22.1 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BOS TAURUS; SOURCE 3 ORGANISM_COMMON: CATTLE; SOURCE 4 ORGANISM_TAXID: 9913; SOURCE 5 TISSUE: KIDNEY; SOURCE 6 MOL_ID: 2; SOURCE 7 ORGANISM_SCIENTIFIC: BOS TAURUS; SOURCE 8 ORGANISM_COMMON: CATTLE; SOURCE 9 ORGANISM_TAXID: 9913; SOURCE 10 TISSUE: KIDNEY KEYWDS CATHEPSIN B, EPOXYSUCCINYL-BASED INHIBITORS, INHIBITOR DESIGN, KEYWDS 2 HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR I.STERN,N.SCHASCHKE,L.MORODER,D.TURK REVDAT 7 13-MAR-24 1SP4 1 COMPND SOURCE REMARK REVDAT 6 11-OCT-17 1SP4 1 REMARK REVDAT 5 12-FEB-14 1SP4 1 REMARK REVDAT 4 13-JUL-11 1SP4 1 VERSN REVDAT 3 24-FEB-09 1SP4 1 VERSN REVDAT 2 13-JUL-04 1SP4 1 JRNL REVDAT 1 04-MAY-04 1SP4 0 JRNL AUTH I.STERN,N.SCHASCHKE,L.MORODER,D.TURK JRNL TITL CRYSTAL STRUCTURE OF NS-134 IN COMPLEX WITH BOVINE CATHEPSIN JRNL TITL 2 B: A TWO-HEADED EPOXYSUCCINYL INHIBITOR EXTENDS ALONG THE JRNL TITL 3 ENTIRE ACTIVE-SITE CLEFT. JRNL REF BIOCHEM.J. V. 381 511 2004 JRNL REFN ISSN 0264-6021 JRNL PMID 15084146 JRNL DOI 10.1042/BJ20040237 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : MAIN REMARK 3 AUTHORS : TURK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 19372 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.194 REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1926 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 41 REMARK 3 SOLVENT ATOMS : 176 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.00000 REMARK 3 B22 (A**2) : 1.00000 REMARK 3 B33 (A**2) : 1.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.014 REMARK 3 BOND ANGLES (DEGREES) : 1.635 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1SP4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-APR-04. REMARK 100 THE DEPOSITION ID IS D_1000021890. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JAN-98 REMARK 200 TEMPERATURE (KELVIN) : 293 REMARK 200 PH : 3.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : YALE MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20320 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 77.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: EPMR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 63.89 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.41 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 3.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 70.98500 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 36.53200 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 36.53200 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 106.47750 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 36.53200 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 36.53200 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 35.49250 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 36.53200 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 36.53200 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 106.47750 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 36.53200 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 36.53200 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 35.49250 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 70.98500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6100 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10930 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -34.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 475 REMARK 475 ZERO OCCUPANCY RESIDUES REMARK 475 THE FOLLOWING RESIDUES WERE MODELED WITH ZERO OCCUPANCY. REMARK 475 THE LOCATION AND PROPERTIES OF THESE RESIDUES MAY NOT REMARK 475 BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 475 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE) REMARK 475 M RES C SSEQI REMARK 475 GLY A 48 REMARK 475 ARG B 49 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 GLU A 3 CD OE1 OE2 REMARK 480 ASN A 47 CB CG OD1 ND2 REMARK 480 LYS B 85 CE NZ REMARK 480 GLU B 122 OE1 OE2 REMARK 480 ASN B 129 OD1 ND2 REMARK 480 LYS B 158 CE NZ REMARK 480 LYS B 166 NZ REMARK 480 LYS B 184 NZ REMARK 480 GLU B 194 CD OE1 OE2 REMARK 480 THR B 253 OG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLU B 66 O HOH B 366 1.23 REMARK 500 CD GLU B 66 O HOH B 366 1.38 REMARK 500 SG CYS A 29 C31 EP2 B 48 1.79 REMARK 500 OE2 GLU B 66 O HOH B 366 1.95 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH B 330 O HOH B 377 7556 1.90 REMARK 500 OD1 ASN B 129 O HOH A 70 5555 1.91 REMARK 500 O HOH B 363 O HOH B 377 7556 1.95 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 15 C - N - CA ANGL. DEV. = 10.2 DEGREES REMARK 500 ASN A 47 N - CA - C ANGL. DEV. = 17.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 45 65.15 -109.13 REMARK 500 ASN A 47 149.45 69.72 REMARK 500 ASN B 95 58.06 35.62 REMARK 500 GLU B 122 123.36 40.46 REMARK 500 ASN B 222 179.47 72.50 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 THE INHIBITOR IS A TWO HEADED EPOXYSUCCINYL INHIBITOR. REMARK 600 THE EPOXY GROUP OPENS UPON REACTION WITH THE ENZYME. REMARK 600 THE INHIBITOR HAS TWO C-TERMINI AND NO N TERMINUS. REMARK 630 REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR REMARK 630 MOLECULE NAME: METHYL N-[(2S)-4-{[(1S)-1-{[(2S)-2- REMARK 630 CARBOXYPYRROLIDIN-1-YL]CARBONYL}-3-METHYLBUTYL]AMINO}-2-HYDROXY-4- REMARK 630 OXOBUTANOYL]-L-LEUCYLGLYCYLGLYCINATE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 EP2 B 48 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: MEU GLY LEU EPO LEU PRO REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EP2 B 48 REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE PROTEIN IS POSTRANSLATIONALLY MODIFIED. AFTER REMARK 999 THE ENZYME IS PROCESSED, THE PEPTIDE BOND BETWEEN REMARK 999 THE RESIDUES 48 49 IS CLEAVED. DBREF 1SP4 A 1 48 UNP P07688 CATB_BOVIN 80 127 DBREF 1SP4 B 49 253 UNP P07688 CATB_BOVIN 128 332 SEQRES 1 A 48 LEU PRO GLU SER PHE ASP ALA ARG GLU GLN TRP PRO ASN SEQRES 2 A 48 CYS PRO THR ILE LYS GLU ILE ARG ASP GLN GLY SER CYS SEQRES 3 A 48 GLY SER CYS TRP ALA PHE GLY ALA VAL GLU ALA ILE SER SEQRES 4 A 48 ASP ARG ILE CYS ILE HIS SER ASN GLY SEQRES 1 B 205 ARG VAL ASN VAL GLU VAL SER ALA GLU ASP MET LEU THR SEQRES 2 B 205 CYS CYS GLY GLY GLU CYS GLY ASP GLY CYS ASN GLY GLY SEQRES 3 B 205 PHE PRO SER GLY ALA TRP ASN PHE TRP THR LYS LYS GLY SEQRES 4 B 205 LEU VAL SER GLY GLY LEU TYR ASN SER HIS VAL GLY CYS SEQRES 5 B 205 ARG PRO TYR SER ILE PRO PRO CYS GLU HIS HIS VAL ASN SEQRES 6 B 205 GLY SER ARG PRO PRO CYS THR GLY GLU GLY ASP THR PRO SEQRES 7 B 205 LYS CYS ASN LYS THR CYS GLU PRO GLY TYR SER PRO SER SEQRES 8 B 205 TYR LYS GLU ASP LYS HIS PHE GLY CYS SER SER TYR SER SEQRES 9 B 205 VAL ALA ASN ASN GLU LYS GLU ILE MET ALA GLU ILE TYR SEQRES 10 B 205 LYS ASN GLY PRO VAL GLU GLY ALA PHE SER VAL TYR SER SEQRES 11 B 205 ASP PHE LEU LEU TYR LYS SER GLY VAL TYR GLN HIS VAL SEQRES 12 B 205 SER GLY GLU ILE MET GLY GLY HIS ALA ILE ARG ILE LEU SEQRES 13 B 205 GLY TRP GLY VAL GLU ASN GLY THR PRO TYR TRP LEU VAL SEQRES 14 B 205 GLY ASN SER TRP ASN THR ASP TRP GLY ASP ASN GLY PHE SEQRES 15 B 205 PHE LYS ILE LEU ARG GLY GLN ASP HIS CYS GLY ILE GLU SEQRES 16 B 205 SER GLU ILE VAL ALA GLY MET PRO CYS THR HET EP2 B 48 41 HETNAM EP2 METHYL N-[(2S)-4-{[(1S)-1-{[(2S)-2-CARBOXYPYRROLIDIN-1- HETNAM 2 EP2 YL]CARBONYL}-3-METHYLBUTYL]AMINO}-2-HYDROXY-4- HETNAM 3 EP2 OXOBUTANOYL]-L-LEUCYLGLYCYLGLYCINATE HETSYN EP2 NS-134 FORMUL 3 EP2 C26 H41 N5 O10 FORMUL 4 HOH *176(H2 O) HELIX 1 1 ALA A 7 TRP A 11 1 5 HELIX 2 2 CYS A 14 GLU A 19 5 6 HELIX 3 3 SER A 28 HIS A 45 1 18 HELIX 4 4 SER B 55 CYS B 63 1 9 HELIX 5 5 GLY B 64 GLY B 68 5 5 HELIX 6 6 ASP B 69 GLY B 73 5 5 HELIX 7 7 PHE B 75 LYS B 86 1 12 HELIX 8 8 TYR B 140 LYS B 144 5 5 HELIX 9 9 ASN B 156 GLY B 168 1 13 HELIX 10 10 ASP B 179 LEU B 181 5 3 HELIX 11 11 ASP B 238 ILE B 242 5 5 SHEET 1 A 3 PHE A 5 ASP A 6 0 SHEET 2 A 3 ILE B 195 GLU B 209 -1 O TRP B 206 N PHE A 5 SHEET 3 A 3 VAL B 170 TYR B 177 -1 N VAL B 176 O GLY B 197 SHEET 1 B 5 PHE A 5 ASP A 6 0 SHEET 2 B 5 ILE B 195 GLU B 209 -1 O TRP B 206 N PHE A 5 SHEET 3 B 5 THR B 212 GLY B 218 -1 O GLY B 218 N ARG B 202 SHEET 4 B 5 PHE B 230 LEU B 234 -1 O PHE B 231 N VAL B 217 SHEET 5 B 5 VAL B 187 TYR B 188 1 N TYR B 188 O LYS B 232 SHEET 1 C 2 GLY B 147 SER B 152 0 SHEET 2 C 2 VAL B 247 PRO B 251 -1 O MET B 250 N CYS B 148 SSBOND 1 CYS A 14 CYS A 43 1555 1555 2.05 SSBOND 2 CYS A 26 CYS B 71 1555 1555 2.03 SSBOND 3 CYS B 62 CYS B 128 1555 1555 2.05 SSBOND 4 CYS B 63 CYS B 67 1555 1555 2.04 SSBOND 5 CYS B 100 CYS B 132 1555 1555 2.05 SSBOND 6 CYS B 108 CYS B 119 1555 1555 2.02 SSBOND 7 CYS B 148 CYS B 252 1555 1555 2.04 CISPEP 1 SER B 137 PRO B 138 0 1.96 SITE 1 AC1 23 GLN A 23 GLY A 24 GLY A 27 SER A 28 SITE 2 AC1 23 CYS A 29 TRP A 30 GLY B 73 GLY B 74 SITE 3 AC1 23 PRO B 76 HIS B 110 HIS B 111 ALA B 173 SITE 4 AC1 23 PHE B 174 SER B 175 GLY B 198 HIS B 199 SITE 5 AC1 23 TRP B 221 GLY B 241 SER B 244 GLU B 245 SITE 6 AC1 23 HOH B 291 HOH B 327 HOH B 354 CRYST1 73.064 73.064 141.970 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013687 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013687 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007044 0.00000